CTGF Mediates Smad-Dependent Transforming Growth Factor β Signaling To Regulate Mesenchymal Cell Proliferation during Palate Development

Molecular and Cellular Biology

Volumn 33, Issue 17, 2013, Pages 3482-3493

  Parada, Carolina ^a   Li, Jingyuan ^a   Iwata, Junichi ^a   Suzuki, Akiko ^a   Chai, Yang ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; CONNECTIVE TISSUE GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; SMAD PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CLEFT PALATE; CONTROLLED STUDY; CRANIOFACIAL DEVELOPMENT; CTGF GENE; DOWN REGULATION; EMBRYO; FEMALE; GENE; GENE EXPRESSION REGULATION; MALE; MESENCHYME CELL; MUTANT; NONHUMAN; OSR2 CRE GENE; PALATE DEVELOPMENT; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SMAD4 GENE; TGFBR2 GENE; WILD TYPE; WNT1 CRE GENE;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; CONNECTIVE TISSUE GROWTH FACTOR; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MALE; MESENCHYMAL STROMAL CELLS; MICE; MICE, TRANSGENIC; MUTATION; PALATE; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 84883494670     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00615-13     Document Type: Article

References (63)

1. Iwata J, Parada C, Chai Y. 2011. The mechanism of TGF-β signaling during palate development. Oral Dis. 17:733-744.
2. Meng L, Bian Z, Torensma R, Von den Hoff JW. 2009. Biological mechanisms in palatogenesis and cleft palate. J. Dent. Res. 88:22-33.
3. Tolarová MM, Cervenka J. 1998. Classification and birth prevalence of orofacial clefts. Am. J. Med. Genet. 75:126-137.
4. Sanford LP, Ormsby I, Gittenberger-de Groot AC, Sariola H, Friedman R, Boivin GP, Cardell EL, Doetschman T. 1997. TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. Development 124:2659-2670.
5. Kaartinen V, Voncken JW, Shuler C, Warburton D, Bu D, Heisterkamp N, Groffen J. 1995. Abnormal lung development and cleft palate in mice lacking TGF-beta3 indicates defects of epithelial-mesenchymal interaction. Nat. Genet. 11:415-421.
6. Proetzel G, Pawlowski SA, Wiles MV, Yin M, Boivin GP, Howles PN, Ding J, Ferguson MWJ, Doetschman T. 1995. Transforming growth factor-beta3 is required for secondary palate fusion. Nat. Genet. 11:409-414.
7. Ito Y, Yeo JY, Chytil A, Han J, Bringas P, Nakajima A, Shuler CF, Moses HL, Chai Y. 2003. Conditional inactivation of Tgfbr2 in cranial neural crest causes cleft palate and calvaria defects. Development 130: 5269-5280.
8. Van Hemelrijk C, Renard M, Loeys B. 2010. The Loeys-Dietz syndrome: an update for the clinician. Curr. Opin. Cardiol. 25:546-551.
9. Shi Y, Massagué J. 2003. Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113:685-700.
10. Iwata J, Hacia JG, Suzuki A, Sanchez-Lara PA, Urata M, Chai Y. 2012. Modulation of noncanonical TGF-β signaling prevents cleft palate in Tgfbr2 mutant mice. J. Clin. Invest. 122:873-885.
11. Massague J. 2000. How cells read TGF-beta signals. Nat. Rev. Mol. Cell Biol. 1:169-178.
12. Xu X, Han J, Ito Y, Bringas P, Jr, Deng C, Ch ai Y. 2008. Ectodermal Smad4 and p38 MAPK are functionally redundant in mediating TGF-β/ BMP signaling during tooth and palate development. Dev. Cell 15:322-329.
13. Chen C-C, Lau LF. 2009. Functions and mechanisms of action of CCN matricellular proteins. Int. J. Biochem. Cell Biol. 41:771-783.
14. Abraham D. 2008. Connective tissue growth factor: growth factor, matricellular organizer, fibrotic biomarker or molecular target for anti-fibrotic therapy in SSc?. Rheumatology 47:v8 -v9.
15. Kono M, Nakamura Y, Suda T, Kato M, Kaida Y, Hashimoto D, Inui N, Hamada E, Miyazaki O, Kurashita S, Fukamachi I, Endo K, Ng PS, Takehara K, Nakamura H, Maekawa M, Chida K. 2011. Plasma CCN2 (connective tissue growth factor; CTGF) is a potential biomarker in idiopathic pulmonary fibrosis (IPF). Clin. Chim. Acta 412:2211-2215.
16. Morales MG, Cabello-Verrugio C, Santander C, Cabrera D, Goldschmeding R, Brandan E. 2011. CTGF/CCN-2 over-expression can directly induce features of skeletal muscle dystrophy. J. Pathol. 225:490-501.
17. Wang Q, Usinger W, Nichols B, Gray J, Xu L, Seeley T, Brenner M, Guo G, Zhang W, Oliver N, Lin A, Yeowell D. 2011. Cooperative interaction of CTGF and TGF-beta in animal models of fibrotic disease. Fibrogenesis Tissue Repair 4:4. doi:10.1186/1755-1536-4-4.
18. Leask A, Sa S, Holmes A, Shiwen X, Black CM, Abraham DJ. 2001. The control of ccn2 (ctgf) gene expression in normal and scleroderma fibroblasts. Mol. Pathol. 54:180-183.
19. Abreu JG, Ketpura NI, Reversade B, De Robertis EM. 2002. Connectivetissue growth factor (CTGF) modulates cell signalling by BMP and TGFbeta. Nat. Cell Biol. 4:599-604.
20. Inoki I, Shiomi T, Hashimoto G, Enomoto H, Nakamura H, Makino K, Ikeda E, Takata S, Kobayashi K, Okada Y. 2002. Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis. FASEB J. 16:219-221.
21. Mercurio S, Latinkic B, Itasaki N, Krumlauf R, Smith JC. 2004. Connective-tissue growth factor modulatesWNTsignalling and interacts with the WNT receptor complex. Development 131:2137-2147.
22. Ivkovic S, Yoon BS, Popoff SN, Safadi FF, Libuda DE, Stephenson RC, Daluiski A, Lyons KM. 2003. Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development 130:2779-2791.
23. Chai Y, Jiang X, Ito Y, Bringas P, Han J, Rowitch DH, Soriano P, McMahon AP, Sucov HM. 2000. Fate of the mammalian cranial neural crest during tooth and mandibular morphogenesis. Development 127: 1671-1679.
24. Oka K, Oka S, Sasaki T, Ito Y, Bringas P, Jr, Nonaka K, Chai Y. 2007. The role of TGF-β signaling in regulating chondrogenesis and osteogenesis during mandibular development. Dev. Biol. 303:391-404.
25. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2 delta delta CT method. Methods 25:402-408.
26. Iwata J, Tung L, Urata M, Hacia JG, Pelikan R, Suzuki A, Ramenzoni L, Chaudhry O, Parada C, Sanchez-Lara PA, Chai Y. 2012. Fibroblast growth factor 9 (FGF9)-pituitary homeobox 2 (PITX2) pathway mediates transforming growth factor β (TGFβ) signaling to regulate cell proliferation in palatal mesenchyme during mouse palatogenesis. J. Biol. Chem. 287:2353-2363.
27. Quandt K, Frech K, Karas H, Wingender E, Werner T. 1995. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 23:4878-4884.
28. Friedrichsen S, Heuer H, Christ S, Winckler M, Brauer D, Bauer K, Raivich G. 2003. CTGF expression during mouse embryonic development. Cell Tissue Res. 312:175-188.
29. Shimo T, Wu C, Billings PC, Piddington R, Rosenbloom J, Pacifici M, Koyama E. 2002. Expression, gene regulation, and roles of Fisp12/CTGF in developing tooth germs. Dev. Dyn. 224:267-278.
30. Blom IE, Goldschmeding R, Leask A. 2002. Gene regulation of connective tissue growth factor: new targets for antifibrotic therapy? Matrix Biol. 21:473-482.
31. Zhao M, New L, Kravchenko VV, Kato Y, Gram H, di Padova F, Olson EN, Ulevitch RJ, Han J. 1999. Regulation of the MEF2 family of transcription factors by p38. Mol. Cell. Biol. 19:21-30.
32. Zhu T, Lobie PE. 2000. Janus kinase 2-dependent activation of p38 mitogen-activated protein kinase by growth hormone. J. Biol. Chem. 275: 2103-2114.
33. Loeys BL, Schwarze U, Holm T, Callewaert BL, Thomas GH, Pannu H, De Backer JF, Oswald GL, Symoens S, Manouvrier S, Roberts JF, Faravelli F, Greco MA, Pyeritz RE, Milewicz DM, Coucke PJ, Cameron DE, Braverman AC, Byers PH, De Paepe AM, Dietz HC. 2006. Aneurysm syndromes caused by mutations in the TGF-β receptor. N. Engl. J. Med. 355:788-798.
34. Zhang Z, Song Y, Zhao X, Zhang X, Fermin C, Chen Y. 2002. Rescue of cleft palate in Msx1-deficient mice by transgenic Bmp4 reveals a network of BMP and Shh signaling in the regulation of mammalian palatogenesis. Development 129:4135-4146.
35. Gao X, Li J, Huang H, Li X. 2008. Connective tissue growth factor stimulates renal cortical myofibroblast-like cell proliferation and matrix protein production. Wound Repair Regen. 16:408-415.
36. Kothapalli D, Grotendorst GR. 2000. CTGF modulates cell cycle progression in cAMP-arrested NRK fibroblasts. J. Cell. Physiol. 182:119-126.
37. Rosenbloom J, Castro SV, Jimenez SA. 2010. Narrative review: fibrotic diseases: cellular and molecular mechanisms and novel therapies. Ann. Intern. Med. 152:159-166.
38. Sirard C, de la Pompa JL, Elia A, Itie A, Mirtsos C, Cheung A, Hahn S, Wakeham A, Schwartz L, Kern SE, Rossant J, Mak TW. 1998. The tumor suppressor gene Smad4/Dpc4 is required for gastrulation and later for anterior development of the mouse embryo. Genes Dev. 12:107-119.
39. Arnott JA, Zhang X, Sanjay A, Owen TA, Smock SL, Rehman S, DeLong WG, Safadi FF, Popoff SN. 2008. Molecular requirements for induction of CTGF expression by TGF-β in primary osteoblasts. Bone 42:871-885.
40. Kwon S, Munroe X, Crawley SC, Lee HY, Spong S, Bradham D, Gum JR, Sleisenger MH, Kim YS. 2007. Expression of connective tissue growth factor in pancreatic cancer cell lines. Int. J. Oncol. 31:693-703.
41. Parisi MS, Gazzerro E, Rydziel S, Canalis E. 2006. Expression and regulation of CCN genes in murine osteoblasts. Bone 38:671-677.
42. Pereira RC, Durant D, Canalis E. 2000. Transcriptional regulation of connective tissue growth factor by cortisol in osteoblasts. Am. J. Physiol. Endocrinol. Metab. 279:E570-E576.
43. Shimo T, Koyama E, Sugito H, Wu C, Shimo S, Pacifici M. 2005. Retinoid signaling regulates CTGF expression in hypertrophic chondrocytes with differential involvement of MAP kinases. J. Bone Miner. Res. 20:867-877.
44. Tang Y, Yang Q, Lu J, Zhang X, Suen D, Tan Y, Jin L, Xiao J, Xie R, Rane M, Li X, Cai L. 2010. Zinc supplementation partially prevents renal pathological changes in diabetic rats. J. Nutr. Biochem. 21:237-246.
45. Ko SO, Chung IH, Xu X, Oka S, Zhao H, Cho ES, Deng C, Chai Y. 2007. Smad4 is required to regulate the fate of cranial neural crest cells. Dev. Biol. 312:435-447.
46. Miyaki M, Kuroki T. 2003. Role of Smad4 (DPC4) inactivation in human cancer. Biochem. Biophys. Res. Commun. 306:799-804.
47. Loeys BL, Chen J, Neptune ER, Judge DP, Podowski M, Holm T, Meyers J, Leitch CC, Katsanis N, Sharifi N, Xu L, Myers LA, Spevack PJ, Cameron DE, De Backer J, Hellemans J, Chen Y, Davis EC, Webb CL, Kress W, Coucke P, Rifkin DB, De Paepe AM, Dietz HC. 2005. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat. Genet. 37:275-281.
48. Biernacka A, Dobaczewski M, Frangogiannis NG. 2011. TGF-β signaling in fibrosis. Growth Factors 29:196-202.
49. Clouthier DE, Comerford SA, Hammer RE. 1997. Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGFbeta1 transgenic mice. J. Clin. Invest. 100:2697-2713.
50. Leask A. 2010. Potential therapeutic targets for cardiac fibrosis. Circ. Res. 106:1675-1680.
51. Safadi FF, Xu J, Smock SL, Kanaan RA, Selim A-H, Odgren PR, Marks SC, Owen TA, Popoff SN. 2003. Expression of connective tissue growth factor in bone: its role in osteoblast proliferation and differentiation in vitro and bone formation in vivo. J. Cell. Physiol. 196:51-62.
52. Junglas B, Yu AHL, Welge-Luessen U, Tamm ER, Fuchshofer R. 2009. Connective tissue growth factor induces extracellular matrix deposition in human trabecular meshwork cells. Exp. Eye Res. 88:1065-1075.
53. Quan T, Shao Y, He T, Voorhees JJ, Fisher GJ. 2010. Reduced expression of connective tissue growth factor (CTGF/CCN2) mediates collagen loss in chronologically aged human skin. J. Invest. Dermatol. 130:415-424.
54. Arnott JA, Lambi AG, Mundy C, Hendesi H, Pixley RA, Owen TA, Safadi FF, Popoff SN. 2011. The role of connective tissue growth factor (CTGF/CCN2) in skeletogenesis. Crit. Rev. Eukaryot. Gene Expr. 21:43-69.
55. Cicha I, Goppelt-Struebe M. 2009. Connective tissue growth factor: context-dependent functions and mechanisms of regulation. BioFactors 35: 200-208.
56. Kubota S, Moritani NH, Kawaki H, Mimura H, Minato M, Takigawa M. 2003. Transcriptional induction of connective tissue growth factor/ hypertrophic chondrocyte-specific 24 gene by dexamethasone in human chondrocytic cells. Bone 33:694-702.
57. Yosimichi G, Nakanishi T, Nishida T, Hattori T, Takano-Yamamoto T, Takigawa M. 2001. CTGF/Hcs24 induces chondrocyte differentiation through a p38 mitogen-activated protein kinase (p38MAPK), and proliferation through a p44/42 MAPK/extracellular-signal regulated kinase (ERK). Eur. J. Biochem. 268:6058-6065.
58. Ono M, Kubota S, Fujisawa T, Sonoyama W, Kawaki H, Akiyama K, Oshima M, Nishida T, Yoshida Y, Suzuki K, Takigawa M, Kuboki T. 2007. Promotion of attachment of human bone marrow stromal cells by CCN2. Biochem. Biophys. Res. Commun. 357:20-25.
59. Wu S-H, Wu X-H, Lu C, Dong L, Chen Z-Q. 2006. Lipoxin A4 inhibits proliferation of human lung fibroblasts induced by connective tissue growth factor. Am. J. Respir. Cell Mol. Biol. 34:65-72.
60. Crawford LA, Guney MA, Oh YA, DeYoung RA, Valenzuela DM, Murphy AJ, Yancopoulos GD, Lyons KM, Brigstock DR, Economides A Gannon M. 2009. Connective tissue growth factor (CTGF) inactivation leads to defects in islet cell lineage allocation and beta-cell proliferation during embryogenesis. Mol. Endocrinol. 23:324-336.
61. Chai Y, Maxson RE, Jr. 2006. Recent advances in craniofacial morphogenesis. Dev. Dyn. 235:2353-2375.
62. Rachfal AW, Brigstock DR. 2005. Structural and functional properties of CCN proteins. Vitam. Horm. 70:69-103.
63. Sysa P, Potter JJ, Liu X, Mezey E. 2009. Transforming growth factor-β1 up-regulation of human α1(I) collagen is mediated by Sp1 and Smad2 transacting factors. DNA Cell Biol. 28:425-434.